Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Treatment of hemangiomas of infancy. Dermatol Ther 2005 Mar-Apr;18(2):151-9 PMID: 15953144

Pubmed ID

15953144

Abstract

Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.

Author List

Barrio VR, Drolet BA

Author

Beth A. Drolet MD Professor in the Dermatology department at Medical College of Wisconsin




Scopus

2-s2.0-21644431713   19 Citations

MESH terms used to index this publication - Major topics in bold

Hemangioma
Humans
Infant, Newborn
Neoplasms, Vascular Tissue
jenkins-FCD Prod-296 4db9d02597e0a2e889e230f853b641c12f1c3ee3